Ticker reaction data · Basic Materials

BIOLARGO INC (BLGO)

BLGO moved a median of 0.00% 30 minutes after news, and -0.05% by the close. How BLGO actually reacts to news — the realized, point-in-time move the market made, measured across 210 labeled events over the last three years with zero look-ahead.

The quantified answer

BLGO’s median reaction, across the day.

0.00%
Median 30-min
Typical reaction 30 minutes after any BLGO news
48%
Moved up
Share of BLGO news events that rose at 30 minutes
-0.05%
Median to close
Where BLGO typically settles by the closing bell
BLGO median reaction to newsBLGO median reaction to news across 4 horizons: 5-min +0.00%, 30-min +0.00%, 60-min -0.03%, to close -0.05%.5-min30-min60-minto close5-min: +0.00%30-min: +0.00%60-min: -0.03%to close: -0.05%+0.00%+0.00%-0.03%-0.05%-0.05%0
Median move vs. the price at the news timestamp, each horizon on its own sample — the counts are in the table below.
BLGO median reaction to news, by horizon. Each rung is measured on the events that traded at that horizon.
HorizonMedian% positiveEvents
5-min0.00%33%184
30-min0.00%48%202
60-min-0.03%43%207
to close-0.05%44%208
Where BLGO reactions landvs 210 measured BLGO reactions
BLGOMiddle 50% · -1.31% to +1.87%Zero: 0.00%Median: 0.00%Median 0.00%-3.00%0+3.00%
Middle 50% of BLGO reactions-1.31% to +1.87%
Median reaction (30-min)0.00%
Measured reactions210
Point-in-time · zero look-ahead

Half of all BIOLARGO INC news events land between -1.31% and +1.87% at 30 minutes.

Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.

Next time, know first

Email me when BLGO moves on news.

One email per qualifying move — the headline, the measured reaction, and how it compares to BLGO's baseline. Nothing else.

▲ BLGO Free · unsubscribe anytime
26M+ news records Operating since 2012 Methodology on SSRN ↗
Latest news

Recent BLGO events, each with its measured reaction.

DateHeadlineEventSource5-minTo close
BioLargo Subsidiary Clyra Medical to Exhibit at SAWC Fall 2026 in Las VegasPress releaseACCESS Newswire+0.00%+2.17%
Form 8-K/A BIOLARGO, INC. For: Sep 10SEC filing · Form 8-KSEC EDGAR-12.07%-7.07%
Form 8-K BIOLARGO, INC. For: Sep 10SEC filing · Form 8-KSEC EDGAR—-0.05%
BioLargo Canada and Tu Nipi Form Indigenous-Led Partnership to Treat Oil Sands Process Water and MorePress releaseACCESS Newswire+8.35%+7.42%
BioLargo Townhall and Q2 2026 Earnings Results Webcast and Conference Call on Thursday, September 10th, 2026 - 4:00 PM Eastern TimePress releaseACCESS Newswire+0.00%+4.84%
BioLargo's Subsidiary Clyra Medical Adds Third Distribution Channel Accelerating Commercial Rollout of ViaClyr Wound Irrigation SolutionPress releaseACCESS Newswire-2.65%-4.76%
BioLargo, Inc. to Present at the Inaugural Nasdaq / LD Micro Summit on September 9, 2026Press releaseACCESS Newswire+0.00%-6.50%
BioLargo to Participate in Gabelli Funds' 4th Annual PFAS Symposium in New YorkPress releaseACCESS Newswire+0.00%+0.00%
BioLargo Reports Second Quarter 2026 Results; Revenue Up 12% Sequentially, Gross Margin Expands to 54%Press releaseACCESS Newswire+1.35%-3.47%
Form 10-Q BIOLARGO, INC. For: Jun 30SEC filing · Form 10-QSEC EDGAR+1.35%-3.47%
BioLargo's Lake Stockholm AEC Installation passes six months of PFAS remediation Topping Two Million GallonsPress releaseACCESS Newswire+7.02%+2.44%
BioLargo Joins New Jersey Institute of Technology-Led PFAS Consortium; President Tonya Chandler Appointed to Board of DirectorsPress releaseACCESS Newswire+0.24%-0.89%
BioLargo Equipment Solutions & Technologies' "PFAS Lady" to Teach PFAS 101 at 41st Annual Tri-State SeminarPress releaseACCESS Newswire+0.00%+1.35%
BioLargo PFAS Treatment Technology Featured in The Disruptive QuarterlyPress releaseACCESS Newswire+7.11%+1.90%
BioLargo Relaunching CupriDyne(R)-Based Consumer Products - Back by Popular Demand and Generated More than $125 Million in Pet-Care SalesPress releaseACCESS Newswire+3.46%+1.46%
BioLargo Engineering Unit Awarded $1.4 Million in U.S. Air Force Environmental Contract RenewalsPress releaseACCESS Newswire-2.44%-3.83%
Form 10-Q BIOLARGO, INC. For: Mar 31SEC filing · Form 10-QSEC EDGAR-1.33%-10.98%
Form 8-K BIOLARGO, INC. For: May 05SEC filing · Form 8-KSEC EDGAR+0.51%-0.58%
BioLargo Subsidiary Clyra Medical Signs Exclusive Distribution Agreement with Al- Hikma FZCO for ViaCLYR(TM) Across the Middle East, North Africa, and Adjacent MarketsPress releaseACCESS Newswire+1.34%-0.49%
BioLargo Signs Memorandum of Understanding with Aquatech to Accelerate Commercialization of PFAS Treatment TechnologyPress releaseACCESS Newswire+0.00%+2.53%
BioLargo to Participate in a Town Hall Meeting Hosted by the BioLargo Shareholder Community on Discord on May 5, 2026Press releaseACCESS Newswire+0.00%+2.53%
Form 8-K BIOLARGO, INC. For: May 04SEC filing · Form 8-KSEC EDGAR+0.00%+2.53%
Form 10-K/A BIOLARGO, INC. For: Dec 31SEC filing · Form 10-KSEC EDGAR-0.07%-0.20%
BioLargo Engineering, Science & Technologies Awarded $1.2 Million Contract to Design Pilot-Scale Minerals Processing Facility for Resource RecoveryPress releaseACCESS Newswire-0.90%+2.84%
Form EFFECT BIOLARGO, INC.SEC filing · Form EFFECTSEC EDGAR+0.00%-1.29%
Form S-1 BIOLARGO, INC.SEC filing · Form S-1SEC EDGAR+0.00%+1.50%
BioLargo CEO Dennis Calvert to Present Global Environmental Leadership Award to Robert Bilott at Nassau County PFAS ForumPress releaseACCESS Newswire—-3.24%
Form 8-K BIOLARGO, INC. For: Mar 20SEC filing · Form 8-KSEC EDGAR+0.00%-1.47%
BioLargo Reports Annual 2025 Operating and Financial ResultsPress releaseACCESS Newswire+2.51%-3.47%
Form 8-K BIOLARGO, INC. For: Mar 05SEC filing · Form 8-KSEC EDGAR—+0.00%
BioLargo Q4 2025 and Year End Earnings Results Webcast and Conference Call on Thursday, March 5th, 2026 - 12:00 PM Eastern TimePress releaseACCESS Newswire—+0.88%
Form 10-K BIOLARGO, INC. For: Dec 31SEC filing · Form 10-KSEC EDGAR+2.57%-0.99%
BioLargo Subsidiary Clyra Medical Highlights Key Opinion Leader Presentation of Exceptional ViaCLYR(TM) Clinical Results at Leading Wound Care SymposiumPress releaseACCESS Newswire+1.49%+3.77%
BioLargo Subsidiary Clyra Medical Technologies Secures First Stocking Order with Advanced Solution for ViaCLYR(TM) Wound Irrigation SolutionPress releaseACCESS Newswire+4.92%+5.29%
BioLargo Installs AEC PFAS Treatment System at Lake Stockholm, New JerseyPress releaseACCESS Newswire-0.15%-3.86%
BioLargo to Present at Sidoti's Micro-Cap Virtual Conference on Thursday January 22nd at 1pm ESTPress releaseACCESS Newswire-1.43%+3.51%
BioLargo Reflects on 2025 Progress and Positions for the Next Phase of Global Infrastructure, Environmental, and Medical InnovationPress releaseACCESS Newswire+0.00%-0.62%
BioLargo Subsidiary BEST Featured in Chemical Engineering Magazine for PFAS BreakthroughPress releaseACCESS Newswire-2.58%+1.05%
Form 8-K BIOLARGO, INC. For: Nov 14SEC filing · Form 8-KSEC EDGAR-1.84%-2.94%
BioLargo Reports Q3 2025 Operating and Financial ResultsPress releaseACCESS Newswire+1.59%-0.55%
Form 10-Q BIOLARGO, INC. For: Sep 30SEC filing · Form 10-QSEC EDGAR+1.59%-0.55%
Form 8-K BIOLARGO, INC. For: Nov 14SEC filing · Form 8-KSEC EDGAR+1.59%-0.55%
BioLargo Q3 2025 Earnings Results Webcast and Conference Call on Friday, November 14th, 2025 - 4:30 PM Eastern TimePress releaseACCESS Newswire+8.51%—
BioLargo Subsidiary Clyra Medical Technologies Forms Strategic Alliance with Advanced Solution to Launch ViaCLYR(TM) Wound Irrigation Solution NationwidePress releaseACCESS Newswire+8.51%—
BioLargo Files Federal Lawsuit Against Pooph Inc.Press releaseACCESS Newswire+0.00%+0.20%
BioLargo Cuts AEC PFAS Treatment Energy Use by >90%, Unlocking Commercial-Scale Water Solutions with Unmatched Total Life Cycle Cost SavingsPress releaseACCESS Newswire+0.00%+0.96%
BioLargo Presentation Deck at LD Micro Event Available OnlinePress releaseACCESS Newswire+0.06%+2.48%
Form 8-K BIOLARGO, INC. For: Oct 20SEC filing · Form 8-KSEC EDGAR+0.06%+2.48%
Biolargo Invites You to the Sustain SoCal 16th Annual Energy Event - A Premier Gathering for Clean Energy InnovationPress releaseACCESS Newswire-2.19%-1.44%
BioLargo to Present Its Cellinity Battery Technology at LD Micro Main Event XIX in San Diego on Monday, October 20, at 2:00 p.m. PTPress releaseACCESS Newswire-2.19%-1.44%

Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the BLGO section they belong to.

Keep exploring

Where else BLGO is measured.

BLGO earnings → · Analyst actions → · SEC filings →

Other Basic Materials names, measured the same way

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.

All Basic Materials names, measured the same way →

Every ticker we measure the same way24

Apple (AAPL)

How AAPL actually reacts to news, measured.

NVIDIA (NVDA)

How NVDA actually reacts to news, measured.

Tesla (TSLA)

How TSLA actually reacts to news, measured.

Microsoft (MSFT)

How MSFT actually reacts to news, measured.

Advanced Micro Devices (AMD)

How AMD actually reacts to news, measured.

Amazon (AMZN)

How AMZN actually reacts to news, measured.

Alphabet (GOOG)

How GOOG actually reacts to news, measured.

Meta Platforms (META)

How META actually reacts to news, measured.

Broadcom (AVGO)

How AVGO actually reacts to news, measured.

JPMorgan Chase (JPM)

How JPM actually reacts to news, measured.

Visa (V)

How V actually reacts to news, measured.

Walmart (WMT)

How WMT actually reacts to news, measured.

Eli Lilly (LLY)

How LLY actually reacts to news, measured.

UnitedHealth Group (UNH)

How UNH actually reacts to news, measured.

Netflix (NFLX)

How NFLX actually reacts to news, measured.

Johnson & Johnson (JNJ)

How JNJ actually reacts to news, measured.

Exxon Mobil (XOM)

How XOM actually reacts to news, measured.

Home Depot (HD)

How HD actually reacts to news, measured.

Costco (COST)

How COST actually reacts to news, measured.

Mastercard (MA)

How MA actually reacts to news, measured.

Oracle (ORCL)

How ORCL actually reacts to news, measured.

Salesforce (CRM)

How CRM actually reacts to news, measured.

Bank of America (BAC)

How BAC actually reacts to news, measured.

Coca-Cola (KO)

How KO actually reacts to news, measured.

Walt Disney (DIS)

How DIS actually reacts to news, measured.

Browse all tickers

Every name we’ve measured, in one place.

Method

How the numbers are made.

How is BIOLARGO INC's median reaction calculated?

Every labeled BLGO news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 210 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.

What counts as a positive reaction?

Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 48% of BLGO's measured events are up at 30 minutes; the rest close the window flat or negative.

How often is this page updated?

The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.

Does BLGO's past reaction predict its next one?

No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.

Stop guessing what the event means

You just saw one reaction.
There are 26 million more.

For investors

Know the next move, measured.

Ticker alerts with the realized reaction — not the headline spin.

Free · no credit card · unsubscribe anytime
For builders

The dataset, one command away.

claude mcp add news-quantified

Then ask Claude: “how does BLGO react to downgrades?” — or pull it raw via REST.

60-second signup on the NQ portal · 100 free credits/mo
26M+ news records, 2006–2026 Operating since 2012 Point-in-time, zero look-ahead Peer-reviewable methodology (SSRN) ↗